HEADER HYDROLASE 07-OCT-03 1R42 TITLE NATIVE HUMAN ANGIOTENSIN CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE TITLE 2 (ACE2) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN I CONVERTING ENZYME 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAINS; COMPND 5 SYNONYM: ANGIOTENSIN CONVERTING ENZYME-LIKE PROTEIN, ANGIOTENSIN COMPND 6 CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: DISORDERED SEGMENT OF COLLECTRIN HOMOLOGY DOMAIN; COMPND 10 CHAIN: B; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: DISORDERED SEGMENT OF COLLECTRIN HOMOLOGY DOMAIN; COMPND 14 CHAIN: C; COMPND 15 ENGINEERED: YES; COMPND 16 MOL_ID: 4; COMPND 17 MOLECULE: DISORDERED SEGMENT OF COLLECTRIN HOMOLOGY DOMAIN; COMPND 18 CHAIN: D; COMPND 19 ENGINEERED: YES; COMPND 20 MOL_ID: 5; COMPND 21 MOLECULE: DISORDERED SEGMENT OF COLLECTRIN HOMOLOGY DOMAIN; COMPND 22 CHAIN: E; COMPND 23 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACE2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PBAC PAK9; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 GENE: ACE2; SOURCE 17 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 18 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 20 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 21 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 22 EXPRESSION_SYSTEM_VECTOR: PBAC PAK9; SOURCE 23 MOL_ID: 3; SOURCE 24 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 25 ORGANISM_COMMON: HUMAN; SOURCE 26 ORGANISM_TAXID: 9606; SOURCE 27 GENE: ACE2; SOURCE 28 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 29 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 30 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 31 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 32 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 33 EXPRESSION_SYSTEM_VECTOR: PBAC PAK9; SOURCE 34 MOL_ID: 4; SOURCE 35 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 36 ORGANISM_COMMON: HUMAN; SOURCE 37 ORGANISM_TAXID: 9606; SOURCE 38 GENE: ACE2; SOURCE 39 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 40 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 41 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 42 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 43 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 44 EXPRESSION_SYSTEM_VECTOR: PBAC PAK9; SOURCE 45 MOL_ID: 5; SOURCE 46 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 47 ORGANISM_COMMON: HUMAN; SOURCE 48 ORGANISM_TAXID: 9606; SOURCE 49 GENE: ACE2; SOURCE 50 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 51 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 52 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 53 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 54 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 55 EXPRESSION_SYSTEM_VECTOR: PBAC PAK9 KEYWDS ZINC METALLOPEPTIDASE DOMAIN, COLLECTRIN HOMOLOGY DOMAIN, NATIVE OR KEYWDS 2 OPEN CONFORMATION, CHLORIDE ION BINDING SITE, ZINC BINDING SITE, KEYWDS 3 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR P.TOWLER,B.STAKER,S.G.PRASAD,S.MENON,D.RYAN,J.TANG,T.PARSONS, AUTHOR 2 M.FISHER,D.WILLIAMS,N.A.DALES,M.A.PATANE,M.W.PANTOLIANO REVDAT 6 29-JUL-20 1R42 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE REVDAT 5 24-JAN-18 1R42 1 JRNL REVDAT 4 13-JUL-11 1R42 1 VERSN REVDAT 3 24-FEB-09 1R42 1 VERSN REVDAT 2 27-APR-04 1R42 1 JRNL REVDAT 1 03-FEB-04 1R42 0 JRNL AUTH P.TOWLER,B.STAKER,S.G.PRASAD,S.MENON,J.TANG,T.PARSONS, JRNL AUTH 2 D.RYAN,M.FISHER,D.WILLIAMS,N.A.DALES,M.A.PATANE, JRNL AUTH 3 M.W.PANTOLIANO JRNL TITL ACE2 X-RAY STRUCTURES REVEAL A LARGE HINGE-BENDING MOTION JRNL TITL 2 IMPORTANT FOR INHIBITOR BINDING AND CATALYSIS. JRNL REF J.BIOL.CHEM. V. 279 17996 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 14754895 JRNL DOI 10.1074/JBC.M311191200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH N.A DALES,A.E.GOULD,J.A.BROWN,E.F.CALDERWOOD,B.GUAN, REMARK 1 AUTH 2 C.A.MINOR,J.M.GAVIN,P.HALES,V.K.KAUSHIK,M.STEWART, REMARK 1 AUTH 3 P.J.TUMMINO,C.S.VICKERS,T.D.OCAIN,M.A.PANTANE REMARK 1 TITL SUBSTRATE-BASED DESIGN OF THE FIRST CLASS OF REMARK 1 TITL 2 ANGIOTENSIN-CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE REMARK 1 TITL 3 (ACE2) INHIBITORS REMARK 1 REF J.AM.CHEM.SOC. V. 124 11852 2002 REMARK 1 REFN ISSN 0002-7863 REMARK 1 DOI 10.1021/JA0277226 REMARK 1 REFERENCE 2 REMARK 1 AUTH C.VICKERS,P.HALES,V.KAUSHIK,L.DICK,J.GAVIN,J.TANG,K.GODBOUT, REMARK 1 AUTH 2 T.PARSONS,E.BARONAS,F.HSIEH,S.ACTON,M.PATANE,A.NICHOLS, REMARK 1 AUTH 3 P.TUMMINO REMARK 1 TITL HYDROLYSIS OF BIOLOGICAL PEPTIDES BY HUMAN REMARK 1 TITL 2 ANGIOTENSIN-CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE REMARK 1 REF J.BIOL.CHEM. V. 277 14838 2002 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.M200581200 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2383730.950 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 47465 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.235 REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 4798 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 81.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5982 REMARK 3 BIN R VALUE (WORKING SET) : 0.3790 REMARK 3 BIN FREE R VALUE : 0.3980 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 659 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5165 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 302 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.61000 REMARK 3 B22 (A**2) : 6.46000 REMARK 3 B33 (A**2) : 0.14000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 11.31000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.40 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.43 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.920 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.040 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.090 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.300 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.420 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 64.55 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1R42 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-OCT-03. REMARK 100 THE DEPOSITION ID IS D_1000020410. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JUN-01 REMARK 200 TEMPERATURE (KELVIN) : 140 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.28 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49286 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : 15.90 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05700 REMARK 200 FOR THE DATA SET : 21.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: MLPHARE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS-HCL, 200 MM MGCL2, 14% PEG REMARK 280 8000, PH 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 51.81900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.73900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 51.81900 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 44.73900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 SER A 5 REMARK 465 TRP A 6 REMARK 465 LEU A 7 REMARK 465 LEU A 8 REMARK 465 LEU A 9 REMARK 465 SER A 10 REMARK 465 LEU A 11 REMARK 465 VAL A 12 REMARK 465 ALA A 13 REMARK 465 VAL A 14 REMARK 465 THR A 15 REMARK 465 ALA A 16 REMARK 465 ALA A 17 REMARK 465 GLN A 18 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLY A 605 O HOH A 915 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLN A 89 OE1 GLN A 89 2756 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 456 CA - CB - CG ANGL. DEV. = 15.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 21 36.02 -66.62 REMARK 500 GLU A 22 -49.48 -134.41 REMARK 500 MET A 82 -35.67 -38.35 REMARK 500 GLU A 87 3.92 -69.15 REMARK 500 ASN A 90 91.77 -57.37 REMARK 500 GLN A 101 40.27 -82.78 REMARK 500 ASN A 137 89.44 -166.42 REMARK 500 HIS A 195 37.14 74.12 REMARK 500 THR A 294 3.36 -61.74 REMARK 500 LYS A 353 49.36 38.53 REMARK 500 ASN A 546 -13.39 79.81 REMARK 500 UNK B 905 -129.45 -86.72 REMARK 500 UNK C 908 114.29 -175.16 REMARK 500 UNK C 913 -118.67 -114.93 REMARK 500 UNK C 914 17.26 -179.41 REMARK 500 UNK C 915 34.24 71.09 REMARK 500 UNK C 916 63.48 -172.12 REMARK 500 UNK C 917 -7.98 -17.99 REMARK 500 UNK C 919 -163.14 168.17 REMARK 500 UNK C 920 111.81 178.64 REMARK 500 UNK C 921 130.01 -18.13 REMARK 500 UNK C 922 -149.93 -79.68 REMARK 500 UNK C 923 -94.86 52.86 REMARK 500 UNK C 924 60.70 20.39 REMARK 500 UNK E 946 105.00 -54.13 REMARK 500 UNK E 948 172.40 -53.82 REMARK 500 UNK E 957 -139.85 55.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 804 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 374 NE2 REMARK 620 2 HIS A 378 NE2 93.0 REMARK 620 3 GLU A 402 OE2 93.0 113.1 REMARK 620 4 GLU A 402 OE1 151.6 90.3 60.0 REMARK 620 5 HOH A 823 O 118.5 96.8 135.5 89.1 REMARK 620 N 1 2 3 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1R4L RELATED DB: PDB REMARK 900 INHIBITOR BOUND HUMAN ANGIOTENSIN CONVERTING ENZYME-RELATED REMARK 900 CARBOXYPEPTIDASE (ACE2) REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE COMPLETE SEQUENCE CRYSTALLIZED BY THE AUTHORS REMARK 999 (RESIDUES 1-740 OF REFERENCE SEQUENCE GB 11225609) REMARK 999 IS AS FOLLOWS: REMARK 999 MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNY REMARK 999 NTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQ REMARK 999 QNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNEIM REMARK 999 ANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGDYW REMARK 999 RGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPS REMARK 999 YISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQAWDAQ REMARK 999 RIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDF REMARK 999 RILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEI REMARK 999 MSLSAATPKHLKSIGLLSPDFQEDNETEINFLLKQALTIVGTLPFTYMLEK REMARK 999 WRWMVFKGEIPKDQWMKKWWEMKREIVGVVEPVPHDETYCDPASLFHVSND REMARK 999 YSFIRYYTRTLYQFQFQEALCQAAKHEGPLHKCDISNSTEAGQKLFNMLRL REMARK 999 GKSEPWTLALENVVGAKNMNVRPLLNYFEPLFTWLKDQNKNSFVGWSTDWS REMARK 999 PYADQSIKVRISLKSALGDKAYEWNDNEMYLFRSSVAYAMRQYFLKVKNQ REMARK 999 MILFGEEDVRVANLKPRISFNFFVTAPKNVSDIIPRTEVEKAIRMSRSRIN REMARK 999 DAFRLNDNSLEFLGIQPTLGPPNQPPVS REMARK 999 THE ELECTRON DENSITY MAP FOR MUCH OF THE COLLECTRIN REMARK 999 HOMOLOGY DOMAIN (RESIDUES 616-740) IS WEAK. ONLY REMARK 999 ABOUT HALF OF THIS DOMAIN WAS VISIBLE IN THE ELECTRON REMARK 999 DENSITY MAP, AND WHAT CAN BE SEEN IS AMBIGUOUS DUE TO REMARK 999 TOPOLOGY AND CONNECTIVITY ISSUES. FOR THIS REASON, REMARK 999 RESIDUES BEGINNING AT 901 ARE LABELED AS UNKNOWN (UNK). REMARK 999 EACH FRAGMENT OF UNKNOWN RESIDUES HAS BEEN ASSIGNED REMARK 999 A UNIQUE CHAIN ID. HOWEVER, IT SHOULD BE UNDERSTOOD REMARK 999 THAT ONLY ONE SEQUENCE (RESIDUES 1-740) WAS CRYSTALLIZED. DBREF 1R42 A 1 615 GB 11225609 NP_068576 1 615 DBREF 1R42 B 901 906 PDB 1R42 1R42 901 906 DBREF 1R42 C 907 926 PDB 1R42 1R42 907 926 DBREF 1R42 D 927 944 PDB 1R42 1R42 927 944 DBREF 1R42 E 945 958 PDB 1R42 1R42 945 958 SEQRES 1 A 615 MET SER SER SER SER TRP LEU LEU LEU SER LEU VAL ALA SEQRES 2 A 615 VAL THR ALA ALA GLN SER THR ILE GLU GLU GLN ALA LYS SEQRES 3 A 615 THR PHE LEU ASP LYS PHE ASN HIS GLU ALA GLU ASP LEU SEQRES 4 A 615 PHE TYR GLN SER SER LEU ALA SER TRP ASN TYR ASN THR SEQRES 5 A 615 ASN ILE THR GLU GLU ASN VAL GLN ASN MET ASN ASN ALA SEQRES 6 A 615 GLY ASP LYS TRP SER ALA PHE LEU LYS GLU GLN SER THR SEQRES 7 A 615 LEU ALA GLN MET TYR PRO LEU GLN GLU ILE GLN ASN LEU SEQRES 8 A 615 THR VAL LYS LEU GLN LEU GLN ALA LEU GLN GLN ASN GLY SEQRES 9 A 615 SER SER VAL LEU SER GLU ASP LYS SER LYS ARG LEU ASN SEQRES 10 A 615 THR ILE LEU ASN THR MET SER THR ILE TYR SER THR GLY SEQRES 11 A 615 LYS VAL CYS ASN PRO ASP ASN PRO GLN GLU CYS LEU LEU SEQRES 12 A 615 LEU GLU PRO GLY LEU ASN GLU ILE MET ALA ASN SER LEU SEQRES 13 A 615 ASP TYR ASN GLU ARG LEU TRP ALA TRP GLU SER TRP ARG SEQRES 14 A 615 SER GLU VAL GLY LYS GLN LEU ARG PRO LEU TYR GLU GLU SEQRES 15 A 615 TYR VAL VAL LEU LYS ASN GLU MET ALA ARG ALA ASN HIS SEQRES 16 A 615 TYR GLU ASP TYR GLY ASP TYR TRP ARG GLY ASP TYR GLU SEQRES 17 A 615 VAL ASN GLY VAL ASP GLY TYR ASP TYR SER ARG GLY GLN SEQRES 18 A 615 LEU ILE GLU ASP VAL GLU HIS THR PHE GLU GLU ILE LYS SEQRES 19 A 615 PRO LEU TYR GLU HIS LEU HIS ALA TYR VAL ARG ALA LYS SEQRES 20 A 615 LEU MET ASN ALA TYR PRO SER TYR ILE SER PRO ILE GLY SEQRES 21 A 615 CYS LEU PRO ALA HIS LEU LEU GLY ASP MET TRP GLY ARG SEQRES 22 A 615 PHE TRP THR ASN LEU TYR SER LEU THR VAL PRO PHE GLY SEQRES 23 A 615 GLN LYS PRO ASN ILE ASP VAL THR ASP ALA MET VAL ASP SEQRES 24 A 615 GLN ALA TRP ASP ALA GLN ARG ILE PHE LYS GLU ALA GLU SEQRES 25 A 615 LYS PHE PHE VAL SER VAL GLY LEU PRO ASN MET THR GLN SEQRES 26 A 615 GLY PHE TRP GLU ASN SER MET LEU THR ASP PRO GLY ASN SEQRES 27 A 615 VAL GLN LYS ALA VAL CYS HIS PRO THR ALA TRP ASP LEU SEQRES 28 A 615 GLY LYS GLY ASP PHE ARG ILE LEU MET CYS THR LYS VAL SEQRES 29 A 615 THR MET ASP ASP PHE LEU THR ALA HIS HIS GLU MET GLY SEQRES 30 A 615 HIS ILE GLN TYR ASP MET ALA TYR ALA ALA GLN PRO PHE SEQRES 31 A 615 LEU LEU ARG ASN GLY ALA ASN GLU GLY PHE HIS GLU ALA SEQRES 32 A 615 VAL GLY GLU ILE MET SER LEU SER ALA ALA THR PRO LYS SEQRES 33 A 615 HIS LEU LYS SER ILE GLY LEU LEU SER PRO ASP PHE GLN SEQRES 34 A 615 GLU ASP ASN GLU THR GLU ILE ASN PHE LEU LEU LYS GLN SEQRES 35 A 615 ALA LEU THR ILE VAL GLY THR LEU PRO PHE THR TYR MET SEQRES 36 A 615 LEU GLU LYS TRP ARG TRP MET VAL PHE LYS GLY GLU ILE SEQRES 37 A 615 PRO LYS ASP GLN TRP MET LYS LYS TRP TRP GLU MET LYS SEQRES 38 A 615 ARG GLU ILE VAL GLY VAL VAL GLU PRO VAL PRO HIS ASP SEQRES 39 A 615 GLU THR TYR CYS ASP PRO ALA SER LEU PHE HIS VAL SER SEQRES 40 A 615 ASN ASP TYR SER PHE ILE ARG TYR TYR THR ARG THR LEU SEQRES 41 A 615 TYR GLN PHE GLN PHE GLN GLU ALA LEU CYS GLN ALA ALA SEQRES 42 A 615 LYS HIS GLU GLY PRO LEU HIS LYS CYS ASP ILE SER ASN SEQRES 43 A 615 SER THR GLU ALA GLY GLN LYS LEU PHE ASN MET LEU ARG SEQRES 44 A 615 LEU GLY LYS SER GLU PRO TRP THR LEU ALA LEU GLU ASN SEQRES 45 A 615 VAL VAL GLY ALA LYS ASN MET ASN VAL ARG PRO LEU LEU SEQRES 46 A 615 ASN TYR PHE GLU PRO LEU PHE THR TRP LEU LYS ASP GLN SEQRES 47 A 615 ASN LYS ASN SER PHE VAL GLY TRP SER THR ASP TRP SER SEQRES 48 A 615 PRO TYR ALA ASP SEQRES 1 B 6 UNK UNK UNK UNK UNK UNK SEQRES 1 C 20 UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK SEQRES 2 C 20 UNK UNK UNK UNK UNK UNK UNK SEQRES 1 D 18 UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK SEQRES 2 D 18 UNK UNK UNK UNK UNK SEQRES 1 E 14 UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK SEQRES 2 E 14 UNK MODRES 1R42 ASN A 90 ASN GLYCOSYLATION SITE MODRES 1R42 ASN A 103 ASN GLYCOSYLATION SITE MODRES 1R42 ASN A 546 ASN GLYCOSYLATION SITE HET NAG A 800 14 HET NAG A 801 14 HET NAG A 802 14 HET CL A 803 1 HET ZN A 804 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM CL CHLORIDE ION HETNAM ZN ZINC ION FORMUL 6 NAG 3(C8 H15 N O6) FORMUL 9 CL CL 1- FORMUL 10 ZN ZN 2+ FORMUL 11 HOH *302(H2 O) HELIX 1 1 GLU A 22 ASN A 53 1 32 HELIX 2 2 THR A 55 THR A 78 1 24 HELIX 3 3 ASN A 90 GLN A 101 1 12 HELIX 4 4 ASN A 103 LEU A 108 5 6 HELIX 5 5 SER A 109 GLY A 130 1 22 HELIX 6 6 GLY A 147 SER A 155 1 9 HELIX 7 7 ASP A 157 VAL A 172 1 16 HELIX 8 8 VAL A 172 ASN A 194 1 23 HELIX 9 9 ASP A 198 GLY A 205 1 8 HELIX 10 10 ARG A 219 TYR A 252 1 34 HELIX 11 11 HIS A 265 LEU A 267 5 3 HELIX 12 12 TRP A 275 ASN A 277 5 3 HELIX 13 13 LEU A 278 VAL A 283 1 6 HELIX 14 14 MET A 297 ALA A 301 5 5 HELIX 15 15 ASP A 303 SER A 317 1 15 HELIX 16 16 GLY A 326 SER A 331 1 6 HELIX 17 17 THR A 365 TYR A 385 1 21 HELIX 18 18 PRO A 389 ARG A 393 5 5 HELIX 19 19 GLY A 399 THR A 414 1 16 HELIX 20 20 THR A 414 ILE A 421 1 8 HELIX 21 21 ASP A 431 VAL A 447 1 17 HELIX 22 22 GLY A 448 GLY A 466 1 19 HELIX 23 23 PRO A 469 ASP A 471 5 3 HELIX 24 24 GLN A 472 ILE A 484 1 13 HELIX 25 25 CYS A 498 SER A 502 5 5 HELIX 26 26 LEU A 503 ASN A 508 1 6 HELIX 27 27 ILE A 513 ALA A 532 1 20 HELIX 28 28 PRO A 538 CYS A 542 5 5 HELIX 29 29 SER A 547 ARG A 559 1 13 HELIX 30 30 PRO A 565 GLY A 575 1 11 HELIX 31 31 VAL A 581 ASN A 599 1 19 HELIX 32 32 UNK D 927 UNK D 943 1 17 HELIX 33 33 UNK E 949 UNK E 951 5 3 SHEET 1 A 2 LYS A 131 ASN A 134 0 SHEET 2 A 2 ASN A 137 LEU A 143 -1 O LEU A 142 N VAL A 132 SHEET 1 B 2 LEU A 262 PRO A 263 0 SHEET 2 B 2 VAL A 487 VAL A 488 1 O VAL A 488 N LEU A 262 SHEET 1 C 2 THR A 347 GLY A 352 0 SHEET 2 C 2 ASP A 355 LEU A 359 -1 O ARG A 357 N TRP A 349 SHEET 1 D 2 UNK C 909 UNK C 912 0 SHEET 2 D 2 UNK E 953 UNK E 956 -1 O UNK E 956 N UNK C 909 SSBOND 1 CYS A 133 CYS A 141 1555 1555 2.04 SSBOND 2 CYS A 344 CYS A 361 1555 1555 2.03 SSBOND 3 CYS A 530 CYS A 542 1555 1555 2.03 LINK ND2 ASN A 90 C1 NAG A 800 1555 1555 1.45 LINK ND2 ASN A 103 C1 NAG A 801 1555 1555 1.45 LINK ND2 ASN A 546 C1 NAG A 802 1555 1555 1.45 LINK NE2 HIS A 374 ZN ZN A 804 1555 1555 1.97 LINK NE2 HIS A 378 ZN ZN A 804 1555 1555 2.26 LINK OE2 GLU A 402 ZN ZN A 804 1555 1555 2.23 LINK OE1 GLU A 402 ZN ZN A 804 1555 1555 2.14 LINK ZN ZN A 804 O HOH A 823 1555 1555 2.46 CISPEP 1 GLU A 145 PRO A 146 0 -0.21 CRYST1 103.638 89.478 112.399 90.00 109.15 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009649 0.000000 0.003351 0.00000 SCALE2 0.000000 0.011176 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009418 0.00000